Use of age-dependent FRAX-based intervention thresholds for Singapore

The health and economic burden of osteoporotic fractures in Singapore and the potential impact of increasing treatment rates through more pharmacological options

(2019) Manju Chandran et al.   Archives of Osteoporosis

Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial

(2018) Lee Shepstone et al.   LANCET

Fracture Prevention with Zoledronate in Older Women with Osteopenia

(2018) Ian R. Reid et al.   NEW ENGLAND JOURNAL OF MEDICINE

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

(2018) J.A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

FRAX® based intervention thresholds for management of osteoporosis in Singaporean women

(2018) M. Chandran et al.   Archives of Osteoporosis

UK clinical guideline for the prevention and treatment of osteoporosis

(2017) J. Compston et al.   Archives of Osteoporosis

A systematic review of intervention thresholds based on FRAX

(2016) John A. Kanis et al.   Archives of Osteoporosis

Burden of high fracture probability worldwide: secular increases 2010–2040

(2015) A. Odén et al.   OSTEOPOROSIS INTERNATIONAL

Systematic review and meta-analysis of the performance of clinical risk assessment instruments for screening for osteoporosis or low bone density

(2015) S. Nayak et al.   OSTEOPOROSIS INTERNATIONAL

Clinician’s Guide to Prevention and Treatment of Osteoporosis

(2014) F. Cosman et al.   OSTEOPOROSIS INTERNATIONAL

Protective Effects of Dietary Carotenoids on Risk of Hip Fracture in Men: The Singapore Chinese Health Study

(2013) Zhaoli Dai et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Osteoporosis in the European Union: medical management, epidemiology and economic burden

(2013) E. Hernlund et al.   Archives of Osteoporosis

The distribution of FRAX®-based probabilities in women from Japan

(2012) John A. Kanis et al.   JOURNAL OF BONE AND MINERAL METABOLISM

A comparison of case-finding strategies in the UK for the management of hip fractures

(2012) H. Johansson et al.   OSTEOPOROSIS INTERNATIONAL

A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis

(2012) S. Lekamwasam et al.   OSTEOPOROSIS INTERNATIONAL

FRAX® with and without Bone Mineral Density

(2011) John A. Kanis et al.   CALCIFIED TISSUE INTERNATIONAL

Can body fat distribution, adiponectin levels and inflammation explain differences in insulin resistance between ethnic Chinese, Malays and Asian Indians?

(2011) H Gao et al.   INTERNATIONAL JOURNAL OF OBESITY

High fracture probability with FRAX® usually indicates densitometric osteoporosis: implications for clinical practice

(2011) W. D. Leslie et al.   OSTEOPOROSIS INTERNATIONAL

2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary

(2010) A. Papaioannou et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK

(2009) J. Compston et al.   MATURITAS

BMD, clinical risk factors and their combination for hip fracture prevention

(2009) H. Johansson et al.   OSTEOPOROSIS INTERNATIONAL

The potential impact of new National Osteoporosis Foundation guidance on treatment patterns

(2009) B. Dawson-Hughes et al.   OSTEOPOROSIS INTERNATIONAL

FRAX™ and the assessment of fracture probability in men and women from the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

The cost-effectiveness of alendronate in the management of osteoporosis

(2007) John A. Kanis et al.   BONE